Reglan Tardive Dyskinesia Lawsuit Update

Tweet

In May 2009, the plaintiffs in the currently filed Reglan lawsuits sought to consolidate their claims through Multidistrict Litigation (MDL), however the MDL panel issued an order denying the request.  This denial of a Reglan MDL simply means that any Reglan lawsuits must proceed as individual lawsuits, which will not be formally coordinated.

Background on Reglan Litigation

Reglan and its generic (metoclopramide) has been linked to a rare neurological disease called tardive dyskinesia.  Tardive dyskinesia is a neurological syndrome caused by the long-term use of neuroleptic drugs, including Reglan and metoclopramide. Neuroleptic drugs are generally prescribed for psychiatric disorders, as well as for some gastrointestinal and neurological disorders.  Tardive dyskinesia is characterized by coordinated, constant movements of the mouth, tongue, jaw, and cheeks.

What You Can Do & How We Can Help – We are committed to helping victims of Tardive Dyskinesia. To our knowledge, we are one of the only law firms in the country actively handling these types of cases. Many lawyers are reluctant to undertake the representation of victims of Reglan induced tardive dyskinesia due to their lack of knowledge in this highly specialized field of litigation.

Do I Have a Reglan Lawuit?

The Defective Drug and Product Liability litigation Groups at our law firm are an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in Tardive Dyskinesia lawsuits. We are handling individual lawsuits nationwide and currently accepting new Reglan induced Tardive Dyskinesia cases in all 50 states.

If you or a loved one have taken Reglan (metoclopramide) and been diagnosed with Tardive Dyskinesia, you should contact us immediately. You may be entitled to compensation and we can help.